CClinicalTrials.gg
RecruitingNCT07379736RecalibrateUpdated Jan 30, 2026

Online Brief Advice Intervention for Heavy Cannabis Users

An interventional study of Educational video and Relaxation video in Cannabis User, sponsored by King's College London. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-30.

Sponsored by King's College London · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Oct 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This project will evaluate whether a brief online intervention focused on cannabis withdrawal can increase awareness and insight about cannabis use disorder among daily cannabis users. The study will employ a randomised controlled trial design comparing an intervention consisting of a short educational video on cannabis withdrawal and personalised feedback on the Cannabis Withdrawal Scale, against a control condition of a relaxation video and mood questionnaire.

The investigators will aim to recruit at least 100 daily cannabis users (minimum 25 days of cannabis use /month and minimum 3.5g cannabis/week [low-medium daily use]) through Prolific, an online research participant platform. Potential participants will complete a brief screening questionnaire (1 minute) to confirm that participants meet inclusion criteria, before randomisation. The experiment will last 10-15 minutes and will include baseline demographic and substance use measures, the intervention or control condition, and outcome measures.

The primary outcome will be cannabis use awareness and insight as measured by the Substance Use Awareness and Insight Scale (SAS). Secondary outcomes will include intention to change cannabis use. This study aims to determine whether a short online intervention can increase awareness about cannabis withdrawal among heavy users. If successful, subsequent studies will be designed to assess these outcomes over the longer-term.

02

Conditions studied

  • Cannabis User

Browse trials for

Keywords

  • Cannabis
  • Brief Intervention
03

In context

Marijuana Abuse

517 studies on the registry are indexed under Marijuana Abuse; 114 are open to participants now.

This study's planned enrollment of 100 is above the median of 60 across 421 interventional studies indexed under Marijuana Abuse.

Browse Marijuana Abuse studies →

Lead sponsor

King's College London is the lead sponsor of 506 studies on the registry; 125 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults (>18 years)
  • Daily/near daily cannabis users (25+ days/month, min. 3.5g/week)
  • Sufficiently fluent in English

Exclusion criteria

Exclusion Criteria:

  • Participant is prescribed medical cannabis by a healthcare professional
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Educational video

    A short educational video on cannabis withdrawal and personalised feedback on the Cannabis Withdrawal Scale

    Other: Educational video

  • Active comparator
    Relaxation video

    A relaxation video and mood questionnaire

    Other: Relaxation video

Interventions

  • OtherEducational video

    Short educational video on cannabis withdrawal and personalised feedback on the Cannabis Withdrawal Scale.

    Also known as: Learning video, Informational video

  • OtherRelaxation video

    Relaxation video and mood questionnaire with personalised feedback

    Also known as: Mindfulness video, Meditation video, Peaceful video

06

What researchers measure

Primary outcomes

  1. Substance (cannabis) use awareness and insight scale (SAS)

    Measured by the Substance Use Awareness and Insight Scale, designed to assess awareness in substance use disorder. Minimum value = 0, maximum value 70. Higher score = worse outcome, less insight and awareness.

    Time frame: Day 1

Secondary outcomes

  1. Intention to change cannabis use

    This outcome measures participants' motivation and readiness to alter their cannabis consumption behaviours following the intervention. The Intention to Change Cannabis Use scale will be used which is adapted from Motivation to Stop Scale. Minimum score = 1, maximum score = 7. Higher score = better outcome, higher motivation to stop.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
  • Denmark Hill
    London, Greater London SE5 9RS, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07379736
Lead sponsor
King's College London
Responsible party
Sponsor
First posted
Jan 30, 2026
Start date
Oct 16, 2025
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Jan 30, 2026

Study contacts

Edward Chesney, MRCPsych
Contact
edward.chesney@kcl.ac.uk
02078365454

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion